Recall Notice: Fentanyl Transdermal Pain Patches Recalled Due to Product Mislabeling

The following is from the FDA MedWatch. Read the recall notice in its entirety here.

Alvogen Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. The 50 mcg/h patches that were included in cartons labeled 12 mcg/h are individually labeled as 50 mcg/h. This transdermal system is manufactured by 3M Drug Delivery Systems. Read the recall notice in its entirety here.